Additionally, Skp2 knockdown suppressed glucose uptake and glycolysis by reduced Glu1 transcription and protein expression in breast cancer cells upon EGF or HRG stimulation, repressing breast cancer development. This evidence concerns the gene SKP2 and breast carcinoma.